Healthcare provider profile · identity verified

Tim Baker, MD

Allopathic & Osteopathic Physicians|Internal Medicine · WASHINGTON, MO · NPI 1760596134

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Tim Baker, MD received $47.47 in general payments during 2025 across 2 reported records.

ABBVIE INC. accounted for 66.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Synthroid by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 117 claims for Ozempic by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$47.47

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$31.59	66.5%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$15.88	33.5%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$47.47	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$31.59	1	2025
Source payment records 2025-07-30 · ABBVIE INC. · $31.59 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$15.88	1	2025
Source payment records 2025-06-18 · Novo Nordisk Inc · $15.88 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$15.88	1	2025
Source payment records 2025-06-18 · Novo Nordisk Inc · $15.88 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	117	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	18	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	117	32

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	903	252
Levothyroxine Sodium	Levothyroxine Sodium	585	153
Omeprazole	Omeprazole	561	150
Losartan Potassium	Losartan Potassium	476	131
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	421	420
Metformin Hcl	Metformin Hcl	410	124
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	342	66
Amlodipine Besylate	Amlodipine Besylate	330	97
Duloxetine Hcl	Duloxetine Hcl	322	66
Metoprolol Succinate	Metoprolol Succinate	300	86
Lisinopril	Lisinopril	250	71
Alprazolam	Alprazolam	246	46
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	243	34
Tramadol Hcl	Tramadol Hcl	237	49
Hydrochlorothiazide	Hydrochlorothiazide	231	69
Allopurinol	Allopurinol	230	58
Meloxicam	Meloxicam	229	68
Carvedilol	Carvedilol	228	66
Pravastatin Sodium	Pravastatin Sodium	227	55
Spironolactone	Spironolactone	226	64
Gabapentin	Gabapentin	221	56
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	220	62
Tamsulosin Hcl	Tamsulosin Hcl	215	59
Famotidine	Famotidine	209	62
Furosemide	Furosemide	199	54
Lorazepam	Lorazepam	198	39
Simvastatin	Simvastatin	197	61
Pantoprazole Sodium	Pantoprazole Sodium	192	50
Metoprolol Tartrate	Metoprolol Tartrate	177	49
Clopidogrel	Clopidogrel Bisulfate	166	49
Albuterol Sulfate Hfa	Albuterol Sulfate	163	55
Jardiance	Empagliflozin	163	35
Glipizide	Glipizide	158	53
Prednisone	Prednisone	155	80
Eliquis	Apixaban	146	32
Potassium Chloride	Potassium Chloride	142	44
Diclofenac Sodium	Diclofenac Sodium	128	39
Montelukast Sodium	Montelukast Sodium	125	33
Azithromycin	Azithromycin	123	72
Memantine Hcl	Memantine Hcl	122	32
Ozempic	Semaglutide	117	32
Ropinirole Hcl	Ropinirole Hcl	117	30
Trazodone Hcl	Trazodone Hcl	116	33
Olanzapine	Olanzapine	111	24
Finasteride	Finasteride	110	32
Fluoxetine Hcl	Fluoxetine Hcl	108	31
Venlafaxine Hcl Er	Venlafaxine Hcl	104	25
Celecoxib	Celecoxib	103	26
Fluticasone Propionate	Fluticasone Propionate	101	35
Oxycodone Hcl	Oxycodone Hcl	101	12
Rosuvastatin Calcium	Rosuvastatin Calcium	96	30
Zolpidem Tartrate	Zolpidem Tartrate	96	22
Escitalopram Oxalate	Escitalopram Oxalate	95	22
Levofloxacin	Levofloxacin	92	71
Diazepam	Diazepam	91	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	36
Tizanidine Hcl	Tizanidine Hcl	84	33
Citalopram Hbr	Citalopram Hydrobromide	81	28
Mirtazapine	Mirtazapine	81	20
Nortriptyline Hcl	Nortriptyline Hcl	81	20
Xarelto	Rivaroxaban	76	14
Bupropion Xl	Bupropion Hcl	74	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	21
Januvia	Sitagliptin Phosphate	73	17
Paroxetine Hcl	Paroxetine Hcl	73	18
Triamcinolone Acetonide	Triamcinolone Acetonide	72	57
Trulicity	Dulaglutide	72	16
Ibuprofen	Ibuprofen	70	19
Oxybutynin Chloride Er	Oxybutynin Chloride	69	19
Warfarin Sodium	Warfarin Sodium	69	16
Alendronate Sodium	Alendronate Sodium	66	13
Baclofen	Baclofen	63	17
Tresiba Flextouch U-100	Insulin Degludec	62	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	20
Sertraline Hcl	Sertraline Hcl	56	17
Cefdinir	Cefdinir	53	49
Arexvy	Rsvpref3 Antigen/As01e/Pf	52	52
Dicyclomine Hcl	Dicyclomine Hcl	52	12
Testosterone Cypionate	Testosterone Cypionate	52	12
Donepezil Hcl	Donepezil Hcl	51	15
Nebivolol Hcl	Nebivolol Hcl	51	12
Mounjaro	Tirzepatide	48	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	47	suppressed
Ipratropium Bromide	Ipratropium Bromide	47	suppressed
Ketoconazole	Ketoconazole	47	29
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	45	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	11
Atenolol	Atenolol	44	11
Bumetanide	Bumetanide	44	18
Naproxen	Naproxen	44	14
Buspirone Hcl	Buspirone Hcl	43	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	33
Doxepin Hcl	Doxepin Hcl	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	37	suppressed
Pregabalin	Pregabalin	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Topiramate	Topiramate	35	suppressed
Cephalexin	Cephalexin	34	31
Lamotrigine	Lamotrigine	34	12
Meclizine Hcl	Meclizine Hcl	34	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Livalo	Pitavastatin Calcium	33	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	12
Fentanyl	Fentanyl	32	suppressed
Fluconazole	Fluconazole	32	17
Carbamazepine	Carbamazepine	31	13
Metolazone	Metolazone	31	13
Verapamil Er	Verapamil Hcl	31	suppressed
Acyclovir	Acyclovir	30	11
Glyburide	Glyburide	30	suppressed
Myrbetriq	Mirabegron	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	25
Sucralfate	Sucralfate	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	15
Folic Acid	Folic Acid	27	suppressed
Amoxicillin	Amoxicillin	26	20
Clonazepam	Clonazepam	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	16
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Methotrexate	Methotrexate Sodium	26	suppressed
Nitroglycerin	Nitroglycerin	26	suppressed
Digoxin	Digoxin	25	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	25	14
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	14
Sulindac	Sulindac	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Estradiol	Estradiol	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	21	suppressed
Ibu	Ibuprofen	20	suppressed
Nystatin	Nystatin	20	12
Ondansetron Odt	Ondansetron	20	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	20	14
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Primidone	Primidone	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Testosterone	Testosterone	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Invokana	Canagliflozin	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	11
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Probenecid	Probenecid	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Valsartan	Valsartan	12	suppressed
Colchicine	Colchicine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Leflunomide	Leflunomide	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Serevent Diskus	Salmeterol Xinafoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$47.47 · 2 records	ABBVIE INC.	Ozempic, Rybelsus, UBRELVY	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error